This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Sexually Transmitted Diseases  • Public Health, Other  • Women's Health  • Women's Health, Other  • Screening  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

JAMA. 2009;302(6):620-621.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

MMWR. 2009;58:362-365

1 figure, 1 table omitted

Chlamydia trachomatis infection is the most common bacterial sexually transmitted disease (STD) in the United States, with more than 2.8 million new cases estimated to occur each year.¹ During 2007, approximately 1.1 million cases of chlamydia were reported to CDC; more than half of these were in females aged 15-25 years.² Untreated chlamydia can progress to pelvic inflammatory disease (PID), infertility, ectopic pregnancy, and chronic pelvic pain. In 1989, the U.S. Preventive Services Task Force (USPSTF) recommended routine chlamydia screening of sexually active young women.³* To evaluate the rates of chlamydia screening among sexually active young females, CDC analyzed data reported by commercial and Medicaid health plans to the Healthcare Effectiveness Data and Information Set (HEDIS) during 2000-2007. The percentage of enrolled sexually active females who were screened for chlamydia was estimated for each of 41 states that had at least five . . . [Full Text of this Article]

Reported by:



CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?